Orchid Pharma shareholding pattern

·Pharma & HealthChart ›

Who owns itSep 2026 quarter

Promoters74.45%+4.61 pts
Foreign investors (FII)0.93%+0.12 pts
Domestic institutions (DII)17.44%−3.31 pts
of which mutual funds16.88%−3.05 pts
of which insurance companies0.01%
Public7.18%

Per cent of all shares; change on the Jun 2026 quarter, in percentage points. As filed with the exchanges.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ORCHPHARMA₹865.00

Orchid Pharma Limited

· Pharma & Health
₹ CrorePeersFDCGUJTHEMIOLCPMOREPENLABRPGLIFEGUFICBIOINNOVACAPUNICHEMLABMcap ₹5,180 Cr
Holding % of Total Shares
12 Months Ending
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Q2 FY27
30/09/2026
Promoter & Group69.8469.8469.8469.8469.8469.8469.8469.8469.8474.45
FII / FPI1.421.942.532.691.401.561.170.870.810.93
DII18.9318.2918.9920.1019.4319.0419.3920.2520.7517.44
Mutual Funds16.9116.7817.4618.7918.5818.0418.0119.4319.9316.88
Latest: 2026-09-30 · 23 quarters of history · click a row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.